MD
Mittie Doyle sold $14K of AVTX stock
Mittie Doyle, Chief Medical Officer of Avalo Therapeutics, Inc. (AVTX), sold 679 shares of AVTX stock worth $14K, per an SEC Form 4 filed Sep 1, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Aug 28, 2026, 4 days before it was made public.
AVTX has moved -62.4% since the trade date, from $19.59 to $7.37 (Nov 16, 2026 close).
- Traded
- Aug 28, 2026
- Disclosed
- Sep 1, 2026
- Filing delay
- 4 days
- Price since
- -62.4%
- Role
- Chief Medical Officer
- Source
- SEC Form 4